These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34895990)

  • 1. Post-transplantation outcomes of sensitized patients receiving durable mechanical circulatory support.
    Youn JC; Zhang X; Nishihara K; Kim IC; Baek SH; Seguchi O; Kransdorf EP; Chang DH; Kittleson MM; Patel JK; Cole RM; Moriguchi JD; Ramzy D; Esmailian F; Kobashigawa JA
    J Heart Lung Transplant; 2022 Mar; 41(3):365-372. PubMed ID: 34895990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three year post heart transplant outcomes of desensitized durable mechanical circulatory support patients.
    Youn JC; Kim D; Jung MH; Kim JJ; Kim IC; Lee HS; Choi JO; Jeon ES; Nishihara K; Seguchi O; Kransdorf EP; Chang DH; Kittleson MM; Patel JK; Cole RM; Moriguchi JD; Ramzy D; Esmailian F; Kobashigawa JA
    J Heart Lung Transplant; 2023 Oct; 42(10):1408-1414. PubMed ID: 37150473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of Pre-transplant Panel-Reactive Antibody on Post-transplantation Outcomes: A Study of Nationwide Heart Transplant Registry Data.
    Kim D; Choi JO; Cho YH; Sung K; Oh J; Cho HJ; Jung SH; Lee HY; Park JJ; Choi DJ; Kang SM; Kim MS; Kim JJ
    Korean Circ J; 2024 Jun; 54(6):325-335. PubMed ID: 38767440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart transplantation in patients bridged with mechanical circulatory support: outcome comparison with matched controls.
    Bartfay SE; Bobbio E; Esmaily S; Bergh N; Holgersson J; Dellgren G; Bollano E; Karason K
    ESC Heart Fail; 2023 Aug; 10(4):2621-2629. PubMed ID: 37343937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does bortezomib influence pre-transplant desensitization therapy or benefit post-heart transplant outcomes for highly sensitized patients?
    Dhillon M; Kobashigawa JA; Kittleson M; Jain R; Patel N; Singer-Englar T; Zhang X; Hakimi M; Aintablian T; Vescio R; Dilibero D; Kransdorf E; Czer L; Nikolova AP; Patel JK
    Clin Transplant; 2024 Jan; 38(1):e15165. PubMed ID: 37837612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Transplant Center Procedural Volume on Survival Outcomes of Heart Transplantation for Children Bridged with Mechanical Circulatory Support.
    Hsieh A; Tumin D; McConnell PI; Galantowicz M; Tobias JD; Hayes D
    Pediatr Cardiol; 2017 Feb; 38(2):280-288. PubMed ID: 27882424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of durable mechanical circulatory support and allosensitization on mortality after heart transplantation.
    Chiu P; Schaffer JM; Oyer PE; Pham M; Banerjee D; Joseph Woo Y; Ha R
    J Heart Lung Transplant; 2016 Jun; 35(6):731-42. PubMed ID: 26856669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience.
    Kumar D; Fattah H; Kimball PM; LeCorchick S; McDougan FA; King AL; Gupta G
    Clin Transpl; 2016; 32():143-151. PubMed ID: 28564532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of anti-human leukocyte antigen antibodies after renal transplantation and their impact on graft outcome.
    de Souza PS; David-Neto E; Panajotopolous N; Agena F; Rodrigues H; Ronda C; David DR; Kalil J; Nahas WC; de Castro MC
    Clin Transplant; 2014 Nov; 28(11):1234-43. PubMed ID: 25142061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after heart transplantation in sensitized patients bridged with ventricular assist devices.
    Fraser CD; Zhou X; Magruder JT; Suarez-Pierre A; Lui C; Grimm JC; Higgins R; Kilic A
    J Card Surg; 2019 Jun; 34(6):474-481. PubMed ID: 31045281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of durable mechanical circulatory support on outcomes of heart-kidney transplantation.
    Chan JL; Patel DC; Megna D; Dimbil SJ; Levine R; Moriguchi J; Czer LS; Kobashigawa JA; Arabia F; Esmailian F
    Interact Cardiovasc Thorac Surg; 2018 Nov; 27(5):773-777. PubMed ID: 29846594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of a national organ sharing policy for highly sensitized patients listed for heart transplantation in Canada.
    Clarke B; Ducharme A; Giannetti N; Kim D; McDonald M; Pflugfelder P; Rajda M; Sénéchal M; Stadnick E; Toma M; Zieroth S; Isaac D
    J Heart Lung Transplant; 2017 May; 36(5):491-498. PubMed ID: 28162932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of angiotensin II type 1 receptor antibodies on post-heart transplantation outcome in Heart Mate II bridged recipients.
    Urban M; Slavcev A; Gazdic T; Ivak P; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):292-7. PubMed ID: 26675563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of anti-HLA antibodies associated with ventricular assist device use in pediatric patients: A United Network for Organ Sharing database analysis.
    Magdo HS; Schumacher KR; Yu S; Gajarski RJ; Friedland-Little JM
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28568969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption.
    Kälble F; Süsal C; Pego da Silva L; Speer C; Benning L; Nusshag C; Pham L; Tran H; Schaier M; Sommerer C; Beimler J; Mehrabi A; Zeier M; Morath C
    Front Med (Lausanne); 2021; 8():781491. PubMed ID: 34977083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptable Post-Heart Transplant Outcomes Support Temporary MCS Prioritization in the New OPTN|UNOS Heart Allocation Policy.
    Reich H; Ramzy D; Moriguchi J; Dimbil S; Levine R; Passano E; Kittleson M; Cole R; Czer L; Chang D; Geft D; Trento A; Chikwe J; Kobashigawa J; Esmailian F
    Transplant Proc; 2021; 53(1):353-357. PubMed ID: 32650992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of using higher-risk donor hearts for candidates with pre-transplant mechanical circulatory support.
    Han J; Moayedi Y; Yang W; Henricksen EJ; Lee R; Purewal S; Chang E; Duclos S; Lyapin A; Feng K; Hiesinger W; Teuteberg JJ; Khush KK
    J Heart Lung Transplant; 2022 Feb; 41(2):237-243. PubMed ID: 34815161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.
    Nath DS; Ilias Basha H; Tiriveedhi V; Alur C; Phelan D; Ewald GA; Moazami N; Mohanakumar T
    J Heart Lung Transplant; 2010 Nov; 29(11):1277-85. PubMed ID: 20615726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantation.
    Nath DS; Angaswamy N; Basha HI; Phelan D; Moazami N; Ewald GA; Mohanakumar T
    Hum Immunol; 2010 Dec; 71(12):1191-6. PubMed ID: 20868717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.